rekovelle
ferring pharmaceuticals a/s - follitropin delta - anovulation - sex hormones and modulators of the genital system, - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle.
rekovelle 72micrograms2.16ml solution for injection cartridges
ferring pharmaceuticals ltd - follitropin delta - solution for injection - 33.33microgram/1ml
rekovelle 36micrograms1.08ml solution for injection cartridges
ferring pharmaceuticals ltd - follitropin delta - solution for injection - 33.33microgram/1ml
rekovelle 12micrograms0.36ml solution for injection cartridges
ferring pharmaceuticals ltd - follitropin delta - solution for injection - 33.33microgram/1ml
rekovelle 12
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 12 mcg / 0.36 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol
rekovelle 36
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 36 mcg / 1.08 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol
rekovelle 72
ferring pharmaceuticals ltd - follitropin delta - solution for injection - follitropin delta 72 mcg / 2.16 ml - follitropin delta - controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (art) such as an in vitro fertilisation (ivf) or intracytoplasmic sperm injection (icsi) cycle. there is no clinical trial experience with rekovelle in the long gnrh agonist protocol
rekovelle solution for injection 12mcg0.36ml
ferring pharmaceuticals private limited - follitropin delta - injection, solution - follitropin delta 12.0mcg
rekovelle solution for injection 36mcg1.08ml
ferring pharmaceuticals private limited - follitropin delta - injection, solution - follitropin delta 36.0 mcg
rekovelle solution for injection 72mcg2.16ml
ferring pharmaceuticals private limited - follitropin delta - injection, solution - follitropin delta 72.0 mcg